Depression Medication - Search News

US FDA approves new nasal spray for depression treatment

Hosted on MSN · 5h

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

CNN on MSN · 1d

FDA approves standalone use of J&J’s ketamine-derived depression treatment

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.

Popular Science · 1d

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

2d

What's the Connection Between Weight & Depression?

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...

News Medical on MSN20h

How your brain learns from rewards might hold the key to treating depression

Using computational models, the researchers studied how the brain’s reward-learning system functions in those with depression ...

Association for Psychological Science8d

Treatment Could Provide Relief for Comorbid Depression and Anxiety

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results